Help support research at The Christie

Thanks to decades of research, cancer death rates have fallen by more than 20% since the 1970s. But at the same time, the number of diagnoses has risen by almost 50%. In short, survival is improving — but incidence is rising faster.

The Christie Charity is committed to supporting The Christie hospital’s vision of changing these statistics by allowing more patients than ever to participate in research by 2030. We’ve pledged to fund this goal with £30m over the next 5 years – but we’ll need your support to do this.

How your support will help research at The Christie

With donations and fundraising from dedicated Christie supporters like you, we want to help experts at The Christie move faster with cancer research. These experts want to:

learn from every patient to improve outcomes for future patients
help more patients take part in research, including clinical trials and real-world evidence studies
harness biomedical and digital innovation to speed up progress
bring life-enhancing and lifesaving treatments to patients sooner

Donate today and help give cancer patients more years, a better quality of life, and hope.

Learn more and support a specific area of research

Sarah Harding Breast Cancer appeal

Sarah Harding – Girls Aloud band member, model and actress – was treated at The Christie in Manchester and tragically died aged 39 in September 2021.

Thanks to funding from the Sarah Harding Breast Cancer Appeal and support from Sarah’s Girls Aloud bandmates, family and friends, groundbreaking breast cancer research has been made possible in her name.

Colorectal and peritoneal cancer

The Colorectal and Peritoneal Oncology Centre (CPOC) at The Christie has an international reputation for treating advanced and early colorectal cancer, appendix and peritoneal tumours.

These types of cancer can be challenging to treat, involving specialist knowledge and care. We need your support to invest in clinical trials and research to deliver better patient outcomes.

The lymphoma service at The Christie

The lymphoma service at The Christie is an internationally recognised centre for the treatment, care and research of lymphoma, a type of blood cancer.

Research at The Christie continues to explore new treatments designed to improve outcomes and quality of life for patients living with lymphoma.

Adenoid Cystic Carcinoma research

Christie patient Ella sadly died with Adenoid Cystic Carcinoma (ACC), a rare head and neck cancer, in December 2021.

Because so few people are diagnosed with ACC, research has been limited. Your support can help find more effective drug treatments for ACC.

What success looks like by 2030

With your help, we want to fund programmes that will:

double — then treble — the number of patients taking part in research
establish 30 new Paterson Research Groups and 30 new clinical academic researchers
treble research income, unlocking more discoveries
deliver 300 international conference presentations, sharing Christie breakthroughs worldwide
bring 30 new innovations into The Christie to improve outcomes
treble research outputs and impact — more grants, fellowships, publications, and practice changing advances
build a learning health system where real-world data and outcomes drive better care and reduce inequalities

Help us change what’s possible with a donation today.

Every breakthrough treatment, every earlier diagnosis, every prevented cancer, every extended life — they all start with research.